Oliver Press and Nancy Ottman Press received the Lymphoma Research Foundation Distinguished Service Award in New York on September 27, 2017
Oliver Press posthumously received the John Ultmann Award for Contributions to Lymphoma Research in New York on October 28, 2017
Oliiver Press posthumously received the American Society of Hematology Mentor Award in Atlanta on December 10, 2017
The Press Lab at the Fred Hutchinson Cancer Research Center is devoted to the investigation of novel treatments for hematologic malignancies including non-Hodgkin's lymphoma, leukemia, and myeloma. We conduct basic laboratory investigations using leukemia and lymphoma cell lines and mouse xenograft models as well as human clinical trials. Agents currently under investigation include monoclonal antibodies, radioimmunoconjugates, immunotoxins, chemotherapeutic agents, and genetically modified cytotoxic T lymphocytes. In the clinical arena, we are continuing our successful program of high dose radioimmunotherapy with stem cell transplantation for B cell lymphomas and have trials planned investigating pretargeted radioimmunotherapy and gene therapy using adoptively transferred cytotoxic T lymphocytes bearing chimeric anti-CD20 receptors.